We have recently used WGS datasets comparing newly diagnosed to lenalidomide- and pomalidomide-refractory MM patients to identify copy loss of chromosome region 2q37, containing CSN members COPS7B and COPS8, as an increasingly common feature usually occurring exclusively to genetic CRBN loss in IMiD-refractory patients. This evidence concerns the gene CRBN and Miyoshi myopathy.